Meta Information
ID:branched-chain-amino-acid-restriction
Name:Branched-Chain Amino AcidRestriction
Schema Version:1.5
Alternate Names
- Low BCAA Diet
Active Compound
null
Intervention Type
dietary_practice
Delivery
Route:
oral
Scope:
- systemic
Regulatory Status
- us:dietary_practice
Indication
Focus:
healthspan
Description:
A dietary strategy to reduce the intake of leucine, isoleucine, and valine to improve metabolic health and potentially extend healthspan.
Typical Protocol
- Reduce intake of BCAA-rich foods like red meat, dairy, and whey protein supplements.
- Prioritize meeting protein needs with lower-BCAA sources, such as certain plant-based proteins.
- Animal studies often involve a ~50% reduction in BCAA intake, but no standard human protocol exists.
Expected Cost Mean
Low Cost:
0
High Cost:
50
Cost Type:
monthly
Description:
Potential cost savings by shifting from animal to plant-based proteins; not insurance covered.
Summary
Branched-chain amino acids (BCAAs), particularly leucine, are potent activators of the mTORC1 signaling pathway, a key regulator of cell growth and metabolism. Chronic mTORC1 activation is linked to accelerated aging. By restricting dietary BCAAs, this strategy aims to dampen mTORC1 activity, mimicking some of the metabolic and longevity benefits of caloric or protein restriction, such as improved insulin sensitivity and glucose homeostasis.
Purpose
Reduces mTORC1 signaling to improve metabolic health and mimic protein restriction.
Card Summary
A dietary strategy to lower intake of leucine, isoleucine, and valine, which dampens mTORC1 signaling to improve metabolic health and potentially slow aging.
Drug Class
null
Drugs In Class
Empty Array
Impact
Score:
3.5
Justification:
Strong animal data for metabolic benefits, but very limited human evidence for healthspan.
Evidence
Grade:
C
Score:
3
Justification:
Robust lifespan extension in rodent models, but lacks long-term human trial data.
Safety
Score:
3.8
Justification:
Risk of muscle loss (sarcopenia) or malnutrition if not carefully implemented, especially in older adults.
Flags
- Poses a significant risk of sarcopenia (age-related muscle loss) if total protein or essential amino acid needs are not met.
- Not recommended for individuals who are pregnant, frail, underweight, or have high protein requirements (e.g., athletes).
- May be difficult to implement and sustain due to the ubiquity of BCAAs in protein sources.
- Long-term effects and safety in humans are unknown.
Verdict
An experimental strategy with strong animal data, but unproven in humans.
Created
2026-05-06T16:39:48.956321Z
Ai Model
Gemini 2.5 Pro (High)